Synairgen starts dosing inhaled COVID-19 drug in phase 3 trialUK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalised COVID-19 patients, after Share XSynairgen starts dosing inhaled COVID-19 drug in phase 3 trialhttps://pharmaphorum.com/news/synairgen-starts-dosing-inhaled-covid-19-drug-in-phase-3-trial/
Coordinating and delivering research in the pandemic: The UK approachThe acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical Share XCoordinating and delivering research in the pandemic: The UK approachhttps://pharmaphorum.com/webinars/uk-covid-coroavirus-research-nihr/
Oral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio techImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from Share XOral COVID-19 vaccine beckons, as ImmunityBio licenses iosBio techhttps://pharmaphorum.com/news/oral-covid-19-vaccine-beckons-as-immunitybio-licenses-iosbio-tech/
EMA says AstraZeneca’s COVID-19 shot could be approved on 29 JanuaryThe European medicines Agency (EMA) said this morning it has received a marketing application from AstraZeneca for its Share XEMA says AstraZeneca’s COVID-19 shot could be approved on 29 Januaryhttps://pharmaphorum.com/news/ema-says-astrazenecas-covid-19-shot-could-be-approved-on-29-january/
Moderna’s COVID-19 vaccine is third approved in UKThe UK has approved the Moderna coronavirus vaccine, hard on the heels of its go-ahead in Europe, although Share XModerna’s COVID-19 vaccine is third approved in UKhttps://pharmaphorum.com/news/modernas-covid-19-vaccine-is-third-approved-in-uk/
IL-6 drugs do work in COVID-19, says UK, as it plans NHS useNew data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus Share XIL-6 drugs do work in COVID-19, says UK, as it plans NHS usehttps://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
UK left trailing as EU quickly approves Moderna’s COVID-19 vaccineThe European Union has approved the coronavirus vaccine from Moderna, leaving the UK trailing because of changes to Share XUK left trailing as EU quickly approves Moderna’s COVID-19 vaccinehttps://pharmaphorum.com/news/uk-left-trailing-as-eu-quickly-approves-modernas-covid-19-vaccine/
Bayer joins the COVID-19 vaccine push, backing CureVac shotShortly after launching large-scale trials of its COVID-19 vaccine candidate, CureVac has the partner it will need to Share XBayer joins the COVID-19 vaccine push, backing CureVac shothttps://pharmaphorum.com/news/bayer-joins-the-covid-19-vaccine-push-backing-curevacs-shot/
UK promises ‘uplift’ in COVID-19 vaccinations as crisis deepensThe UK government has promised a “massive uplift” in the number of coronavirus vaccinations carried out this week, Share XUK promises ‘uplift’ in COVID-19 vaccinations as crisis deepenshttps://pharmaphorum.com/news/uk-promises-uplift-in-covid-vaccinations-as-crisis-deepens/